Work

383-P: Intranasal (IN) Naloxone as a Novel Therapy to Preserve Hypoglycemia Counterregulatory (CR) Response after Exercise in Type 1 Diabetes (T1D)

Year: 2023

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Diabetes

DOI: 10.2337/db23-383-p

Authors: AMIR MOHEET, LYNN E. EBERLY, SINDHURA INKOLLU, ANJALI KUMAR, ALISON C. ALVEAR, YUAN ZHANG, LISA COLES, NICHOLAS EVANOFF, DONALD R. DENGEL, ELIZABETH R. SEAQUIST

Language: English

Topic: Diabetes Management and Research

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4381376885

FWCI: 0.165

Cites:

Cited by: 1

Related to: 10